Dr. Kurie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
Medical College of GeorgiaResidency, Internal Medicine, 1983 - 1986
Brody School of Medicine at East Carolina UniversityClass of 1983
Certifications & Licensure
TX State Medical License 1993 - 2024
NY State Medical License 1992 - 1994
MD State Medical License 1986 - 1992
GA State Medical License 1984 - 1989- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Elected Member The American Society for Clinical Investigation, 2001
Clinical Trials
- Celecoxib as a Chemopreventive Agent in Current and Former Smokers Start of enrollment: 2001 Nov 01
Publications & Presentations
PubMed
- 1 citationsUnleashing the Potential of 1,3-Diketone Analogues as Selective LH2 Inhibitors.Juhoon Lee, Hou-Fu Guo, Shike Wang, Yazdan Maghsoud, Erik Antonio Vázquez-Montelongo, Zhifeng Jing, Rae M Sammons, Eun Jeong Cho, Pengyu Ren, G Andrés Cisneros, Jonath...> ;ACS Medicinal Chemistry Letters. 2023 Oct 12
- EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer.Guan-Yu Xiao, Xiaochao Tan, Bertha L Rodriguez, Don L Gibbons, Shike Wang, Chao Wu, Xin Liu, Jiang Yu, Mayra E Vasquez, Hai T Tran, Jun Xu, William K Russell, Cara Hay...> ;Proceedings of the National Academy of Sciences of the United States of America. 2023 Jul 11
- 4 citationsComputational Investigation of a Series of Small Molecules as Potential Compounds for Lysyl Hydroxylase-2 (LH2) Inhibition.Yazdan Maghsoud, Erik Antonio Vázquez-Montelongo, Xudong Yang, Chengwen Liu, Zhifeng Jing, Juhoon Lee, Matthew Harger, Ally K Smith, Miguel Espinoza, Hou-Fu Guo, Jonat...> ;Journal of Chemical Information and Modeling. 2023 Feb 13
- Join now to see all
Journal Articles
- JAK1/STAT3 Activation Through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung CancerJohn D Minna, Jonathan M Kurie, J Jack Lee, Vassiliki A Papadimitrakopoulou, Neda Kalhor, Roy S Herbst, Clinical Cancer Research
Press Mentions
MD Anderson Research Highlights for June 30, 2021June 30th, 2021- Novel Kras-Mutant Murine Models of Non-Small Cell Lung Cancer Possessing Co-Occurring Oncogenic Mutations and Increased Tumor Mutational BurdenJanuary 28th, 2021
Antiviral Treatments Lead Researchers to Develop Possible Cancer DrugJanuary 23rd, 2020- Join now to see all
Grant Support
- Regulation Of Lung Cancer Metastasis By Mir-200National Cancer Institute2011–2012
- Inflammation In Oncogenic K-Ras-Induced Lung TumorigenesisNational Cancer Institute2008–2012
- Kinase Signaling In Lung TumorigenesisNational Cancer Institute2004–2012
- P-3: Targeting Tumor Microenvironment In NsclcNational Cancer Institute2008–2011
- Mediators Of Oncogenic KRAS In Lung AdenocarcinomaNational Cancer Institute2006–2010
- Igfbp 6--A Target In Lung Cancer PreventionNational Cancer Institute2001–2006
- Retinoid Signaling In New Lung Cancer Prevention ModelsNational Cancer Institute2000–2005
- Trial Of Celecoxib In Lung Cancer ChemopreventionNational Cancer Institute2001–2002
- Retinoid Prevention Of Lung Cancer In Former SmokersNational Cancer Institute1996–2002
- Retinoid Signaling In Human Bronchial Epithelial CellNational Cancer Institute1995–1999
- Role Of FOS, Jun, RAR In Ra-Induced TC DifferentiationNational Cancer Institute1990–1992
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
